These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 2827906)
41. Release of peptide leukotrienes from rat Kupffer cells. Sakagami Y; Mizoguchi Y; Seki S; Kobayashi K; Morisawa S; Yamamoto S Biochem Biophys Res Commun; 1988 Oct; 156(1):217-21. PubMed ID: 2845972 [TBL] [Abstract][Full Text] [Related]
42. Effects of platelet activating factor (PAF) and its receptor antagonist BN 52021 on isolated perfused guinea-pig heart. Viossat I; Chapelat M; Chabrier PE; Braquet P Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):189-94. PubMed ID: 2622972 [TBL] [Abstract][Full Text] [Related]
43. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids. Chen CR; Voelkel NF; Chang SW Am J Respir Crit Care Med; 1994 Jan; 149(1):34-40. PubMed ID: 8111595 [TBL] [Abstract][Full Text] [Related]
44. A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat. MacNaughton WK; Catto-Smith AG; Gall DG J Pharmacol Exp Ther; 1992 Feb; 260(2):773-9. PubMed ID: 1738123 [TBL] [Abstract][Full Text] [Related]
45. PAF-induced histamine release in the isolated perfused rat kidney. Alessandrì MG; Giovannini L; Mian M; Palla R; Gattai V; Ciangherotti A; Bertelli A Int J Tissue React; 1988; 10(1):33-8. PubMed ID: 2456276 [TBL] [Abstract][Full Text] [Related]
46. Potentiation of leukotriene formation in pulmonary and vascular tissue. Lefer AM; Roth DM; Lefer DJ; Smith JB Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):186-9. PubMed ID: 6089002 [TBL] [Abstract][Full Text] [Related]
47. Effect of systemic platelet-activating factor (PAF) on the rabbit spinal cord microcirculation. Lindsberg PJ; Jacobs TP; Paakkari IA; Hallenbeck JM; Feuerstein G J Lipid Mediat; 1990; 2(1):41-58. PubMed ID: 2133267 [TBL] [Abstract][Full Text] [Related]
48. Leukotriene C4 action and metabolism in the isolated perfused bullfrog heart. Herman RP; Heller RS; Canavan CM; Herman CA Can J Physiol Pharmacol; 1988 Aug; 66(8):980-4. PubMed ID: 2846140 [TBL] [Abstract][Full Text] [Related]
49. Effects of platelet-activating factor on myocardial contraction and myocardial relaxation of isolated perfused guinea pig hearts. Felix SB; Baumann G; Ahmad Z; Hashemi T; Niemczyk M; Berdel WE J Cardiovasc Pharmacol; 1990 Nov; 16(5):750-6. PubMed ID: 1703596 [TBL] [Abstract][Full Text] [Related]
50. The effect of vasoactive intestinal peptide and calcitonin gene-related peptide on peptidoleukotriene release from platelet activating factor stimulated rat lungs and ionophore stimulated guinea pig lungs. Di Marzo V; Tippins JR; Morris HR Biochem Int; 1986 Dec; 13(6):933-42. PubMed ID: 2432897 [TBL] [Abstract][Full Text] [Related]
51. Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused rat hearts. Sibelius U; Grandel U; Buerke M; Kiss L; Klingenberger P; Heep M; Bournelis E; Seeger W; Grimminger F Crit Care Med; 2003 Mar; 31(3):683-8. PubMed ID: 12626969 [TBL] [Abstract][Full Text] [Related]
52. Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. Stahl GL; Lefer AM Blood Vessels; 1987; 24(1-2):24-30. PubMed ID: 3567363 [TBL] [Abstract][Full Text] [Related]
53. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor. Hsueh W; Gonzalez-Crussi F; Arroyave JL J Clin Invest; 1986 Jul; 78(1):108-14. PubMed ID: 3459734 [TBL] [Abstract][Full Text] [Related]
54. Platelet-activating factor-induced vasoconstriction in rat isolated, perfused hearts: contribution of cyclo-oxygenase and lipoxygenase arachidonic acid metabolites. Stewart AG; Piper PJ Pharmacol Res Commun; 1986 Aug; 18 Suppl():163-72. PubMed ID: 3095850 [TBL] [Abstract][Full Text] [Related]
55. Age-related effects of platelet activating factor (PAF) in the isolated perfused rat heart. Abete P; Ferrara N; Leosco D; Caccese P; Landino P; Sederino S; Balbi R; Rengo F J Mol Cell Cardiol; 1992 Dec; 24(12):1399-407. PubMed ID: 1293314 [TBL] [Abstract][Full Text] [Related]
56. Prostaglandin F2 alpha mediates platelet-activating factor-stimulated atrial natriuretic factor release from the isolated rat heart. Rayner TE; Chen BN; McLoughlin JW; Menadue MF; Norman RJ; Oliver JR Endocrinology; 1993 Sep; 133(3):1108-15. PubMed ID: 8365356 [TBL] [Abstract][Full Text] [Related]
57. Interactions of prostanoids with the platelet activating factors. Mentz P; Mentz G; Giessler C; Mest HJ Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):13-6. PubMed ID: 1279731 [TBL] [Abstract][Full Text] [Related]
58. Platelet activating factor (PAF) and its role in cardiac injury. Lefer AM Prog Clin Biol Res; 1989; 301():53-60. PubMed ID: 2678133 [TBL] [Abstract][Full Text] [Related]
59. Molecular and cellular actions of platelet-activating factor in rat heart cells. Massey CV; Kohout TA; Gaa ST; Lederer WJ; Rogers TB J Clin Invest; 1991 Dec; 88(6):2106-16. PubMed ID: 1661298 [TBL] [Abstract][Full Text] [Related]
60. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. Sibelius U; Grandel U; Buerke M; Mueller D; Kiss L; Kraemer HJ; Braun-Dullaeus R; Haberbosch W; Seeger W; Grimminger F Circulation; 2000 Jan 4-11; 101(1):78-85. PubMed ID: 10618308 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]